🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger

RecruitingNAAges 18 Years - 75 YearsAllKonya Beyhekim Training and Research Hospital
NCT07256522 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients aged 18-75 years who present with trigger finger to a tertiary rehabilitation hospital and agree to participate will be included in the study. Participants will be randomly allocated into three groups using block randomization. The first group will use a static finger splint that blocks the proximal interphalangeal joint for 6 weeks, along with a home exercise program. The second group will receive paraffin bath therapy, and the third group will receive peloidotherapy, both in combination with home exercises. All patients will receive education about the disease and activity modification. The finger joint-restricting splint and exercises will be applied for 6 weeks. Evaluations will be conducted at baseline, at the end of the 3rd week, and at the end of the 6th week by a blinded assessor. No analgesic or anti-inflammatory medication will be permitted during the study, and patie

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Being between 18 and 75 years of age and willing to participate in the study * Having a diagnosis of idiopathic single trigger finger, Grade 2-3 Exclusion Criteria: * Patients with triggering in more than one finger * Patients with triggering at the A3 pulley or with Grade 1 or Grade 4 trigger finger * Patients with thumb (pollex) trigger finger * Patients who have undergone any injection or interventional procedure (release surgery) for trigger finger within the past 6 months * Patients who have received physical therapy for the hand within the past 6 months * Patients currently using corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs) * Patients with inflammatory or autoimmune rheumatologic diseases such as rheumatoid arthritis, systemic lupus erythematosus, gout, or psoriatic arthritis * Patients with other musculoskeletal disorders (e.g., carpal tunnel syndrome, de Quervain's tenosynovitis, symptomatic hand osteoarthritis, or Dupuytren's contracture) or neurological diseases (e.g., stroke-related hemiparesis, spinal cord injury, brachial plexus injury, multiple sclerosis, or Parkinsonism) affecting the same hand * Patients with musculoskeletal disorders causing pain and/or limitation in the proximal upper extremity on the affected side (e.g., periarthritis, lateral epicondylitis, mononeuropathy, or radiculopathy) * Patients with significant metabolic diseases (e.g., hypothyroidism, Cushing's syndrome, or uncontrolled diabetes) * Patients with any condition that may interfere with treatment, such as open wounds, rashes, local infections, or active malignant disease of the hand * Patients with a history of hand trauma (chronic or repetitive) * Patients unwilling to complete the self-assessment questionnaires either independently or with assistance * Pregnant women
💊

What it tests

  • Finger orthosis
  • Paraffin bath
  • Peloidotherapy
📍

Where

1 site
Konya Beyhekim Training and Research Hospital
Konya, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy